[ad_1]
The RUTI vaccine against COVID-19, developed by a researcher at the German hospital Trias i Pujol in Catalonia (Spain) and produced by the pharmaceutical company Archivel Farma, is the first of Spanish origin to receive authorization to perform international clinical studies from perform in Argentina, EFE reports Wednesday.
As the company reported, the vaccine, originally developed against tuberculosis, is expected to be effective against other viral infections such as the novel coronavirus, so it has received approval from the National Administration of Medicines, Foods and Medical Devices (ANMAT) in Argentina. for testing. clinics, writes agerpres.ro.
Read also: Adrian Streinu Cercel: ‘Don’t wash yourself, don’t wear a mask, but then don’t be surprised if you get sick’
This is a 9-month double-blind double-blind study to evaluate the effectiveness of the RUTI vaccine in preventing infection and reducing the mortality rate caused by the SARS-CoV-2 virus on the turn of medical staff.
The vaccine was developed by Dr. Pere-Joan Cardona, of the Can Ruti Microbiology Service, and is based on the so-called “innate trained immunity”, in other words on stimulating the body’s immunity with the vaccine and “providing it with memory. “. , to generate a better and faster response to virus exposure.
Read also: Traian Berbeceanu: “The people of Bucharest understand and know that the measures are in support of them and are respected”
If proven effective, RUTI could be the basis for broad-spectrum antiviral vaccines, thanks to its alternative mechanism to the generation of antibodies produced by conventional vaccination. This new therapeutic option could also be used as a first solution in epidemics caused by new viruses or in the case of mutations suffered by a pandemic virus as a result of which existing vaccines lose their initial effectiveness.
It could also be used to boost immunity in sections of the population that do not respond to specific vaccines or in addition to antibody-generating vaccines, such as those developed against COVID-19.
Read also: Codrin Ștefănescu: ‘Liviu is bad with his health, he has big spinal problems’
After receiving the approval of the Argentine authorities, the company RUTI Immune, created by Archivel Farma to produce the vaccine, has already started the procedures so that the doses can reach the South American country where they will be administered to a number of 369 employees of different health centers. . .
In Spain, according to the company, the vaccine will soon be tested in a clinical trial, similar to the one in Argentina, through the German Trias i Pujol Institute (IGTP).
Read also: Traian Berbeceanu: “The event at the Patriarchate was special, in the 3 days there were tens of thousands of people, I think the organization was exceptional”.
.
[ad_2]
Source link
